FA
VMD icon

Friess Associates’s Viemed Healthcare VMD Stock Holding History

Friess Associates’s Portfolio VMD Stock Details VMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-210,000
Closed -$1M – 133
2020
Q1 		$1M Buy
+210,000
New +$1.04M 0.1% 94

Other funds holding VMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HIM
Hillsdale Investment Management Toronto, Ontario, Canada $3.68B AUM 62.12% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CSC
Cove Street Capital El Segundo, California $76.6M AUM 36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Friess Associates's VMD Position: Q2 2020 in Review

Friess Associates sold out of Viemed Healthcare (VMD) in Q2 2020, closing a stake of 210,000 shares — an estimated $1M sold.

Friess Associates first reported a position in VMD in Q1 2020 and held it in 1 quarter. The position peaked at $1M in Q1 2020. 92 funds tracked by Wall St. Rank hold VMD as of Q2 2020.

  • Friess Associates reported no remaining Viemed Healthcare position as of Q2 2020 after selling out during the quarter.
  • Friess Associates sold 210,000 Viemed Healthcare shares in Q2 2020, an estimated $1M.
  • Friess Associates first reported a position in Viemed Healthcare in Q1 2020 and held it in 1 quarter.
  • Friess Associates's Viemed Healthcare position peaked at $1M in Q1 2020.
  • 92 funds tracked by Wall St. Rank held Viemed Healthcare as of Q2 2020.

Based on Friess Associates's 13F filing for Q2 2020, filed 14 Aug 2020.